Viking Therapeutics IncNASDAQ:VKTX
- LAST PRICE51.6300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots53.0000/ 5
- Ask / Lots53.3400/ 1
- Open / Previous Close--- / 51.6300
- Day Range---
- 52 Week Range
- Volume12,416
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VKTX |
|---|---|---|
| 09:32 ET | 67210 | 51.96 |
| 09:33 ET | 15823 | 51.2 |
| 09:35 ET | 18236 | 50.8983 |
| 09:37 ET | 6384 | 50.895 |
| 09:39 ET | 9012 | 50.775 |
| 09:42 ET | 10223 | 50.88 |
| 09:44 ET | 10839 | 50.8402 |
| 09:46 ET | 4561 | 50.8515 |
| 09:48 ET | 14362 | 51.0248 |
| 09:50 ET | 19931 | 51.25 |
| 09:51 ET | 6292 | 51.295 |
| 09:53 ET | 20412 | 50.9 |
| 09:55 ET | 24703 | 51.26 |
| 09:57 ET | 12932 | 51.4114 |
| 10:00 ET | 13269 | 51.783 |
| 10:02 ET | 10384 | 51.65 |
| 10:04 ET | 39869 | 51.39 |
| 10:06 ET | 9488 | 51.34 |
| 10:08 ET | 22026 | 51.275 |
| 10:09 ET | 8255 | 51.36 |
| 10:11 ET | 28395 | 51.29 |
| 10:13 ET | 6550 | 51.39 |
| 10:15 ET | 6120 | 51.59 |
| 10:18 ET | 7885 | 51.759 |
| 10:20 ET | 13328 | 51.79 |
| 10:22 ET | 13856 | 52.15 |
| 10:24 ET | 18670 | 51.985 |
| 10:26 ET | 10695 | 52.055 |
| 10:27 ET | 20003 | 51.97 |
| 10:29 ET | 8155 | 51.73 |
| 10:31 ET | 13006 | 51.79 |
| 10:33 ET | 6030 | 51.825 |
| 10:36 ET | 4465 | 51.6893 |
| 10:38 ET | 11547 | 52.01 |
| 10:40 ET | 14109 | 51.5 |
| 10:42 ET | 13409 | 51.5 |
| 10:44 ET | 9547 | 51.4276 |
| 10:45 ET | 5720 | 51.6025 |
| 10:47 ET | 3671 | 52.07 |
| 10:49 ET | 7239 | 51.86 |
| 10:51 ET | 5858 | 51.885 |
| 10:54 ET | 3910 | 51.91 |
| 10:56 ET | 6250 | 51.995 |
| 10:58 ET | 13688 | 52.1061 |
| 11:00 ET | 1843 | 52.15 |
| 11:02 ET | 10590 | 52.2 |
| 11:03 ET | 8404 | 52.2 |
| 11:05 ET | 27054 | 52.469 |
| 11:07 ET | 10742 | 52.425 |
| 11:09 ET | 6618 | 52.3 |
| 11:12 ET | 7720 | 52.32 |
| 11:14 ET | 6678 | 52.365 |
| 11:16 ET | 9459 | 52.43 |
| 11:18 ET | 18995 | 52.5 |
| 11:20 ET | 12409 | 52.25 |
| 11:21 ET | 6478 | 52.165 |
| 11:23 ET | 5803 | 52.15 |
| 11:25 ET | 10241 | 52.2 |
| 11:27 ET | 6043 | 52.39 |
| 11:30 ET | 3125 | 52.35 |
| 11:32 ET | 6468 | 52.365 |
| 11:34 ET | 4620 | 52.48 |
| 11:36 ET | 18011 | 52.68 |
| 11:38 ET | 11825 | 52.2001 |
| 11:39 ET | 2467 | 52.33 |
| 11:41 ET | 7579 | 52.34 |
| 11:43 ET | 4500 | 52.46 |
| 11:45 ET | 4289 | 52.44 |
| 11:48 ET | 851 | 52.355 |
| 11:50 ET | 4436 | 52.3 |
| 11:52 ET | 1817 | 52.43 |
| 11:54 ET | 19925 | 52.35 |
| 11:56 ET | 7965 | 52.5087 |
| 11:57 ET | 3562 | 52.525 |
| 11:59 ET | 10079 | 52.79 |
| 12:01 ET | 17705 | 52.87 |
| 12:03 ET | 6543 | 52.83 |
| 12:06 ET | 8539 | 52.78 |
| 12:08 ET | 18848 | 53.095 |
| 12:10 ET | 37428 | 53.205 |
| 12:12 ET | 5818 | 53.195 |
| 12:14 ET | 5804 | 53.24 |
| 12:15 ET | 13095 | 53.0791 |
| 12:17 ET | 13511 | 53.22 |
| 12:19 ET | 7291 | 53.27 |
| 12:21 ET | 4968 | 53.3456 |
| 12:24 ET | 15670 | 53.299 |
| 12:26 ET | 11048 | 53.3299 |
| 12:28 ET | 12462 | 53.2801 |
| 12:30 ET | 6747 | 53.38 |
| 12:32 ET | 15493 | 53.435 |
| 12:33 ET | 36198 | 53.415 |
| 12:35 ET | 4848 | 53.48 |
| 12:37 ET | 1950 | 53.5 |
| 12:39 ET | 3208 | 53.52 |
| 12:42 ET | 10028 | 53.7593 |
| 12:44 ET | 16279 | 53.87 |
| 12:46 ET | 27155 | 54.03 |
| 12:48 ET | 16830 | 54.1439 |
| 12:50 ET | 10930 | 54.0737 |
| 12:51 ET | 22820 | 54.1024 |
| 12:53 ET | 23779 | 53.825 |
| 12:55 ET | 7234 | 53.7093 |
| 12:57 ET | 5518 | 53.61 |
| 01:00 ET | 5796 | 53.68 |
| 01:02 ET | 4217 | 53.6895 |
| 01:04 ET | 2817 | 53.71 |
| 01:06 ET | 2837 | 53.7625 |
| 01:08 ET | 14711 | 53.79 |
| 01:09 ET | 5544 | 53.87 |
| 01:11 ET | 4584 | 53.73 |
| 01:13 ET | 4139 | 53.78 |
| 01:15 ET | 10880 | 53.785 |
| 01:18 ET | 6615 | 53.79 |
| 01:20 ET | 4986 | 53.9 |
| 01:22 ET | 6341 | 54 |
| 01:24 ET | 13247 | 54.09 |
| 01:26 ET | 20980 | 54.1699 |
| 01:27 ET | 12478 | 54.05 |
| 01:29 ET | 8950 | 54.05 |
| 01:31 ET | 24675 | 54.083 |
| 01:33 ET | 3870 | 53.88 |
| 01:36 ET | 25328 | 53.81 |
| 01:38 ET | 4873 | 53.725 |
| 01:40 ET | 14177 | 53.64 |
| 01:42 ET | 15662 | 53.515 |
| 01:44 ET | 4994 | 53.63 |
| 01:45 ET | 4793 | 53.7454 |
| 01:47 ET | 6484 | 53.66 |
| 01:49 ET | 4302 | 53.65 |
| 01:51 ET | 3737 | 53.49 |
| 01:54 ET | 5667 | 53.5046 |
| 01:56 ET | 2390 | 53.47 |
| 01:58 ET | 5540 | 53.24 |
| 02:00 ET | 7081 | 53.21 |
| 02:02 ET | 6735 | 53.11 |
| 02:03 ET | 8391 | 53.14 |
| 02:05 ET | 2138 | 53.05 |
| 02:07 ET | 6948 | 52.97 |
| 02:09 ET | 4664 | 52.9 |
| 02:12 ET | 4164 | 52.73 |
| 02:14 ET | 4092 | 52.705 |
| 02:16 ET | 4157 | 52.65 |
| 02:18 ET | 3559 | 52.56 |
| 02:20 ET | 5164 | 52.5 |
| 02:21 ET | 8444 | 52.45 |
| 02:23 ET | 2664 | 52.45 |
| 02:25 ET | 10551 | 52.38 |
| 02:27 ET | 3422 | 52.4 |
| 02:30 ET | 12546 | 52.27 |
| 02:32 ET | 8405 | 52.22 |
| 02:34 ET | 12325 | 52.42 |
| 02:36 ET | 2764 | 52.27 |
| 02:38 ET | 5425 | 52.265 |
| 02:39 ET | 3792 | 52.3 |
| 02:41 ET | 7895 | 52.17 |
| 02:43 ET | 16013 | 52.22 |
| 02:45 ET | 3925 | 52.32 |
| 02:48 ET | 7139 | 52.22 |
| 02:50 ET | 15227 | 52.0599 |
| 02:52 ET | 7719 | 51.94 |
| 02:54 ET | 5315 | 52.02 |
| 02:56 ET | 4939 | 51.971 |
| 02:57 ET | 6924 | 52.08 |
| 02:59 ET | 7205 | 51.94 |
| 03:01 ET | 2173 | 51.955 |
| 03:03 ET | 4296 | 51.96 |
| 03:06 ET | 6590 | 51.96 |
| 03:08 ET | 8070 | 52.06 |
| 03:10 ET | 4463 | 52.06 |
| 03:12 ET | 11556 | 52.025 |
| 03:14 ET | 6170 | 52.09 |
| 03:15 ET | 21703 | 52.15 |
| 03:17 ET | 4580 | 52.08 |
| 03:19 ET | 5271 | 52.13 |
| 03:21 ET | 4942 | 52.14 |
| 03:24 ET | 675 | 52.14 |
| 03:26 ET | 9594 | 52.24 |
| 03:28 ET | 3982 | 52.17 |
| 03:30 ET | 10485 | 52.1 |
| 03:32 ET | 17995 | 52.005 |
| 03:33 ET | 10399 | 51.965 |
| 03:35 ET | 17946 | 51.96 |
| 03:37 ET | 21712 | 51.965 |
| 03:39 ET | 10558 | 51.935 |
| 03:42 ET | 27826 | 51.97 |
| 03:44 ET | 16145 | 52.16 |
| 03:46 ET | 10323 | 52.1308 |
| 03:48 ET | 10584 | 52.09 |
| 03:50 ET | 13068 | 52 |
| 03:51 ET | 26685 | 51.98 |
| 03:53 ET | 33878 | 51.92 |
| 03:55 ET | 36146 | 51.685 |
| 03:57 ET | 31114 | 51.78 |
| 04:00 ET | 245848 | 51.63 |
Nov 20, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 4:15PM ET on Wednesday Nov 20, 2024 by Dow Jones
4:15PM ET on Wednesday Nov 20, 2024 by Dow JonesVKTX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Viking Therapeutics, Inc., from 7:31AM ET on Wednesday Nov 20, 2024 by Dow Jones
7:31AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 19, 2024
Nov 18, 2024
Did Viking Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - VKTX, from 10:16PM ET on Monday Nov 18, 2024 by Dow Jones
10:16PM ET on Monday Nov 18, 2024 by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 9:52PM ET on Monday Nov 18, 2024 by Dow Jones
9:52PM ET on Monday Nov 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Viking Therapeutics Inc | 5.8B | -55.1x | --- |
Cytokinetics Inc | 5.6B | -8.8x | --- |
Nuvalent Inc | 6.1B | -26.7x | --- |
Crinetics Pharmaceuticals Inc | 5.1B | -15.3x | --- |
Avidity Biosciences Inc | 5.1B | -14.7x | --- |
Krystal Biotech Inc | 5.2B | 103.1x | --- |
Company Information
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for treatment of metabolic and endocrine disorders. The Company's clinical programs include VK2809, an orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders, which is being evaluated in a Phase II b study for the treatment of biopsy-confirmed non-alcoholic steatohepatitis (NASH) and fibrosis. The Company is developing VK0214, which is also an orally available, tissue and receptor-subtype selective agonist of TRb for X-linked adrenoleukodystrophy (X-ALD), a rare X-linked, inherited neurological disorder characterized by a breakdown in the protective barriers surrounding brain and nerve cells. It is also developing VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors for the treatment of various metabolic disorders.
Contact Information
- Headquarters
- 9920 Pacific Heights Blvd, Suite 350SAN DIEGO, CA, United States 92121
- Phone
- 858-704-4660
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Lawson Macartney
- President, Chief Executive Officer, Director
- Brian Lian
- Chief Financial Officer
- Greg Zante
- Chief Operating Officer
- Marianne Mancini
- Independent Director
- Matthew Foehr
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.8B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 111.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.91 |
EPS | $-0.94 |
Book Value | $3.48 |
P/E Ratio | -55.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
